| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/22/2004 | CN1167796C Antithrombin nucleotides and proteins from horn fly |
| 09/22/2004 | CN1167793C Polypeptides encoded by human lipase-like gene, compositions and methods |
| 09/22/2004 | CN1167467C Antiswelling medicine |
| 09/22/2004 | CN1167466C Oral medicinal preparation |
| 09/22/2004 | CN1167465C Fusion anticaries DNA vaccine and its preparation |
| 09/21/2004 | US6794498 Method of eliminating inhibitory/instability regions of mRNA |
| 09/21/2004 | US6794361 Conotoxin polypeptide inhibits neuronal amine transporters; incontinence, cardiovascular disorders |
| 09/21/2004 | US6794360 Using histacalin protein in the manufacture of a medicament for the treatment or prevention of allergic rhinitis |
| 09/21/2004 | US6794174 Full-length infectious cDNA clones of tick borne flavivirus |
| 09/21/2004 | US6794169 Enzymatic polypeptide for use in the biosynthesis of glycans |
| 09/21/2004 | US6794166 Identification and molecular characterization of proteins, expressed in the Ixodes ricinus salivary glands |
| 09/21/2004 | US6794151 c-myc coding region determinant-binding protein (CRD-BP) and its nucleic acid sequence |
| 09/21/2004 | US6794150 Detecting liver disorders in mammals; obtain sample, measure amount of marker, compare to control, diagnose liver disorder |
| 09/21/2004 | US6794131 Lage-1 tumor associated nucleic acids |
| 09/21/2004 | US6794128 Methods of selecting internalizing antibodies |
| 09/21/2004 | US6793928 Vaccines with an LTB adjuvant |
| 09/21/2004 | US6793927 Isolated pasteurella haemolytica bacterium which comprises a mutation in an aroa gene, wherein the mutation attenuates the bacterium |
| 09/21/2004 | US6793924 Monoclonal antibody which specifically recognizes and forms complex with protein located on surface of activated t cells and thereby inhibits t cell activation of b cells |
| 09/21/2004 | US6793923 Vaccines with enhanced immune response and methods for their preparation |
| 09/21/2004 | US6793921 Specific antibodies for use in preparation of pharmaceutical compositions useful in the prevention or treatment of gastritis, gastric ulcers and duodenal ulcers |
| 09/21/2004 | US6793919 Methods for treating rheumatoid arthritis using IL-17 antagonists |
| 09/21/2004 | CA2195668C Identification of a human cytomegalovirus gene region involved in down-regulation of mhc class i heavy chain expression |
| 09/16/2004 | WO2004078986A1 Infectious flavivirus pseudo-particles containing functional prm and/or e proteins |
| 09/16/2004 | WO2004078977A1 Subunits of the adenovirus fiber protein and uses thereof as vaccines |
| 09/16/2004 | WO2004078949A2 Genes of an otitis media isolate of nontypeable haemophilus influenzae |
| 09/16/2004 | WO2004078928A2 T cell regulation |
| 09/16/2004 | WO2004078918A2 Materials and methods relating to therapy and diagnosis using targeting of cells that express dcal-hy polypeptides |
| 09/16/2004 | WO2004078912A2 Chicken rna polymerase i promoter and the use thereof |
| 09/16/2004 | WO2004078909A2 Identification of antigen epitopes |
| 09/16/2004 | WO2004078907A2 Streptococcus pyogenes antigens |
| 09/16/2004 | WO2004078776A2 Ny-eso-1 peptides which bind to class ii molecules and uses thereof |
| 09/16/2004 | WO2004078215A2 Use of antibody conjugated deoxycytidine kinase for adept |
| 09/16/2004 | WO2004078203A2 Infectious bronchitis virus with an altered spike gene |
| 09/16/2004 | WO2004078201A1 Treatment of sinusitis related chronic facial pain and headache with botulinum toxin |
| 09/16/2004 | WO2004078147A2 Oxytocin controlled release formulations and methods of using same |
| 09/16/2004 | WO2004078146A2 Trans-membrane-antibody induced inhibition of apoptosis |
| 09/16/2004 | WO2004078137A2 Antitumor agents comprising a targeting portion and an immune response triggering portion |
| 09/16/2004 | WO2004078135A2 LIGANDS THAT BIND TO THE AMYLOID-β PRECURSOR PEPTIDE AND RELATED MOLECULES AND USES THEREOF |
| 09/16/2004 | WO2004078130A2 Posh interacting proteins and related methods |
| 09/16/2004 | WO2004078099A2 Compositions and methods for the generation of protective immune response against malaria |
| 09/16/2004 | WO2004078022A2 Methods of treating disease by transplantation of developing allogeneic or xenogeneic organs or tissues |
| 09/16/2004 | WO2004052278A3 Escape mutants of newcastle disease virus as marker vaccines |
| 09/16/2004 | WO2004050846A8 Wall teichoic acid as a target for anti-staphylococcal therapies and vaccines |
| 09/16/2004 | WO2004048404A3 Multiple variants of meningococcal protein nmb1870 |
| 09/16/2004 | WO2004047794A3 An allergen dosage form |
| 09/16/2004 | WO2004047762A3 Methods for treating cancer using porimin as a target |
| 09/16/2004 | WO2004041157A3 Group b streptococcus vaccine |
| 09/16/2004 | WO2004030631A3 Anti-cancer and anti-infectious disease compositions and methods for using same |
| 09/16/2004 | WO2004026905A3 Transporter/channel proteins |
| 09/16/2004 | WO2004025263A3 Protein and peptide expression for passive immunity |
| 09/16/2004 | WO2004016230A3 Identification of the endothelial receptor for the angiostatin kringle-5 |
| 09/16/2004 | WO2003105665A3 Epstein-barr virus-specific immunization |
| 09/16/2004 | WO2003096974A3 ORIENTIA TSUTSUGAMUSHI TRUNCATED RECOMBINANT OUTER MENBRANE PROTEIN (r47) AND (r56) VACCINES DIAGNOSTICS AND THERAPEUTICS FOR SCRUB TYPHUS AND HIV INFECTION |
| 09/16/2004 | WO2003088898A3 Compositions and methods for the diagnosis and treatment of tumor |
| 09/16/2004 | WO2003083041A8 Cripto-specific antibodies |
| 09/16/2004 | WO2003074000A3 Eleutherosides as adjuncts for vaccines and immune modulation |
| 09/16/2004 | WO2003065971A3 Non-myeloablative tolerogenic treatment with tyrphostins |
| 09/16/2004 | WO2003052048A3 Nucleic acid-associated proteins |
| 09/16/2004 | WO2003045318A3 Manipulation of cytokine levels using cd83 gene products |
| 09/16/2004 | WO2003043583A3 Treatment of immunological disorders using anti-cd30 antibodies |
| 09/16/2004 | WO2003040307A3 Heteromultimeric tnf ligand family members |
| 09/16/2004 | WO2003026690A9 Incapacitated whole-cell immunogenic bacterial compositions |
| 09/16/2004 | WO2003020884A3 Method for rapid generation of mature dendritic cells |
| 09/16/2004 | WO2002069691A3 Immunogenic hiv peptides for use as reagents and vaccines |
| 09/16/2004 | US20040181820 Nucleic acids for transforming fish cells and methods for their use |
| 09/16/2004 | US20040181046 Comprises nucleotide sequences coding fungal protein for diagnosis, prevetion and treatment of respiratory system disorders |
| 09/16/2004 | US20040181045 Antisense nucleotide sequences for treatment, diagnosis and prevention of viral and autoimmune disorders |
| 09/16/2004 | US20040181039 Canine immunoglobulin variable domains, caninized antibodies, and methods for making and using them |
| 09/16/2004 | US20040181036 Mutant forms of cholera holotoxin as an adjuvant |
| 09/16/2004 | US20040180829 Compounds and methods for regulating bacterial growth and pathogenesis |
| 09/16/2004 | US20040180407 Novel G protein coupled receptor protein, DNA and its ligand |
| 09/16/2004 | US20040180389 antigen bearing target and a fusion polypeptide which can bind to a cell surface binding moiety (e.g., a carbohydrate) and serve as a ligand for a cell surface polypeptide; immunotherapy; e.g. fusion protein of a lectin and a ligand of a cell surface receptor of an antigen presenting cell |
| 09/16/2004 | US20040180354 Comprises polypeptides which are displayable on antigen presenting cells of immune system for use in prevention and treatment of infection and vaccine development; immunotherapy |
| 09/16/2004 | US20040180344 Novel therapeutic targets in cancer |
| 09/16/2004 | US20040180338 Mutated eukariotic transalation initiation factor 2 alpha kinase3, eif2ak3, in patients with neonatal insuluin-dependant diabetes and multiple epiphyseal dyslapsia (wolcott-rallison syndrome) |
| 09/16/2004 | US20040180329 Synthetic HIV gag genes |
| 09/16/2004 | US20040180064 For immunizing a cat against a hemorrhagic feline calicivirus (hFCV) |
| 09/16/2004 | US20040180062 Administering by whole-body spray, an effective amount of a vaccine comprising a live avirulent derivative of an enteropathogenic bacteria to the bird |
| 09/16/2004 | US20040180060 For the reduction of E. coli O157:H7 colonization in animals |
| 09/16/2004 | US20040180059 For alleviating symptoms of systemic lupus erythematosus (SLE) in a human subject |
| 09/16/2004 | US20040180058 Vaccine compositions and methods |
| 09/16/2004 | US20040180056 Mid-life vaccine and methods for boosting anti-mycobacterial immunity |
| 09/16/2004 | US20040180052 Bind to AILIM (activation inducible lymphocyte immunomodulatory molecule, also referred to as ICOS (inducible co-stimulator); human monoclonal antibodies which bind to AILIM or a portion thereof; for treating disorders related to the delayed allergy |
| 09/16/2004 | US20040180051 Comprising an antibody against human tissue factor (human TF), for therapy of pulmonary thrombosis or deep venous thrombosis |
| 09/16/2004 | US20040180050 Inverse skewing of the lymphocyte repertoire for therapy and prevention of disease |
| 09/16/2004 | US20040180046 Bispecific molecules and uses thereof |
| 09/16/2004 | US20040180035 Administering to the mammal (i) an immunoconjugate comprising an antibody binding site capable of binding the preselected cell-type and a cytokine capable of inducing a said immune response against the preselected cell-type, and (ii) an angiogenesis inhibitor to enhance immune response |
| 09/16/2004 | US20040180001 antitumor |
| 09/16/2004 | US20040177807 Electrospraying apparatus and method for coating particles |
| 09/16/2004 | CA2796381A1 Genes of an otitis media isolate of nontypeable haemophilus influenzae |
| 09/16/2004 | CA2545779A1 Compositions and methods for the generation of protective immune response against malaria |
| 09/16/2004 | CA2518237A1 Antitumor agents comprising a targeting portion and an immune response triggering portion |
| 09/16/2004 | CA2518157A1 Treatment of sinusitis related chronic facial pain and headache with botulinum toxin |
| 09/16/2004 | CA2518119A1 Trans-membrane-antibody induced inhibition of apoptosis |
| 09/16/2004 | CA2517959A1 Expansion of renewable stem cell populations using modulators of pi 3-kinase |
| 09/16/2004 | CA2517916A1 Methods of treating disease by transplantation of developing allogeneic or xenogeneic organs or tissues |
| 09/16/2004 | CA2517899A1 Genes of an otitis media isolate of nontypeable haemophilus influenzae |
| 09/16/2004 | CA2517767A1 Ligands that bind to the amyloid-.beta. precursor peptide and related molecules and uses thereof |
| 09/16/2004 | CA2517601A1 Infectious flavivirus pseudo-particles containing functional prm-e envelope proteins |
| 09/16/2004 | CA2517525A1 Posh interacting proteins and related methods |